HPV vaccine study finds near-zero cervical cancer death risk before 30

Published by Albis · 19 Jun 2026

A Lancet study in England found no cervical cancer deaths among women aged 20 to 24 between 2020 and 2024 after school-age HPV vaccination, with researchers estimating around 200 lives saved so far

• • The finding is a powerful evidence point for long-run vaccination policy and cancer-prevention funding.
• • Public-health transmission chain.
• • Without vaccination, around 23 deaths would have been expected in that age group.
• • The study, published in The Lancet and funded by Cancer Research UK, examined nationwide mortality data after England introduced HPV vaccination for girls aged 12 to 13 in 2008.